ストックスクリーナーアプリを入手
76.90
0.81%
-0.63
Halozyme Therapeutics Inc (HALO) 最新ニュース
Halozyme up after guidance raise, Morgan Stanley upgrade - MSN
Intech Investment Management LLC Raises Stock Position in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Jacobs Levy Equity Management Inc. Makes New $11.64 Million Investment in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics (NASDAQ:HALO) Sets New 1-Year HighTime to Buy? - MarketBeat
United Services Automobile Association Acquires New Shares in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics stock hits all-time high at 76.34 USD - Investing.com
Halozyme Therapeutics stock hits all-time high at 76.34 USD By Investing.com - Investing.com Nigeria
Great Lakes Advisors LLC Purchases 98,190 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics, Inc. $HALO Shares Bought by Panoramic Capital LLC - MarketBeat
Halozyme Therapeutics, Inc. $HALO Shares Bought by Clark Capital Management Group Inc. - MarketBeat
Redwood Investments LLC Has $2.57 Million Stock Holdings in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Teza Capital Management LLC Buys New Position in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics, Inc. $HALO Holdings Lifted by Hancock Whitney Corp - MarketBeat
EFG Asset Management North America Corp. Has $6.57 Million Stock Holdings in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Cutter Capital Management LP Purchases New Shares in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Does Halozyme Stock Offer More Potential After Its Recent Strong Price Run in 2025? - Yahoo Finance
Halozyme Therapeutics (NASDAQ:HALO) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Zacks.com featured highlights include Halozyme Therapeutics, Leidos and TransUnion - sharewise.com
Zacks Research Issues Optimistic Estimate for HALO Earnings - MarketBeat
Price Channel Expanding on Halozyme Therapeutics Inc.’s ChartVolume Spike & AI Powered Market Trend Analysis - beatles.ru
Canada Pension Plan Investment Board Lowers Position in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics (NASDAQ:HALO) Reaches New 1-Year HighStill a Buy? - MarketBeat
Halozyme Therapeutics Inc. stock prediction for this weekWeekly Trade Summary & Real-Time Buy Signal Notifications - Newser
RYBREVANT®▼ (amivantamab) plus LAZCLUZE®▼ (lazertinib) reduces acquired resistance versus osimertinib in first-line EGFR-mutated advanced non-small cell lung cancer - GlobeNewswire Inc.
Pinnacle Wealth Planning Services Inc. Purchases New Holdings in Halozyme Therapeutics, Inc. $HALO - MarketBeat
What drives Halozyme Therapeutics Inc.’s stock priceJuly 2025 Price Swings & Stepwise Trade Signal Guides - خودرو بانک
Zacks.com featured highlights include Halozyme Therapeutics, Phibro, Leidos and PDD Holdings - sharewise.com
What to do if you’re stuck in Halozyme Therapeutics Inc.Market Rally & Smart Investment Allocation Tips - Newser
Bet on These 3 Stocks With Upgraded Broker Ratings for Robust Returns - Yahoo Finance
Forecasting Halozyme Therapeutics Inc. price range with options dataDividend Hike & Weekly High Return Stock Forecasts - Newser
Steamboat Capital Partners LLC Sells 99,751 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Is Halozyme Therapeutics Inc. stock entering bullish territory2025 Market WrapUp & Safe Capital Growth Tips - Newser
Halozyme Therapeutics Inc. stock chart pattern explainedLong Setup & Technical Entry and Exit Alerts - Newser
Applying Wyckoff theory to Halozyme Therapeutics Inc. stockMarket Volume Report & Accurate Intraday Trade Tips - Newser
Halozyme Therapeutics Inc. recovery potential after sell off2025 Key Lessons & Weekly Top Stock Performers List - Newser
Halozyme Therapeutics CEO Torley sells $4.44 million in stock By Investing.com - Investing.com Canada
Halozyme at Wells Fargo Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Halozyme Therapeutics (HALO): Revolutionizing Drug Delivery and Scaling Commercial Success - AInvest
Halozyme Therapeutics Presents at Wells Fargo 20th Annual Healthcare Conference 2025: Q&A Session with Helen Torley - AInvest
Transcript : Halozyme Therapeutics, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-04-2025 01 - MarketScreener
4 PEG-Rated GARP Stocks That Offer Both Value and Growth - Zacks Investment Research
Halozyme Therapeutics stock reaches all-time high at 74.79 USD By Investing.com - Investing.com Australia
Rafferty Asset Management LLC Cuts Holdings in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Leading vs lagging indicators on Halozyme Therapeutics Inc. performance2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - Newser
Will Halozyme Therapeutics Inc. outperform the marketQuarterly Trade Summary & Free Safe Entry Trade Signal Reports - Newser
What to expect from Halozyme Therapeutics Inc. in the next 30 daysPortfolio Gains Summary & Free Community Supported Trade Ideas - Newser
Trend analysis for Halozyme Therapeutics Inc. this weekJuly 2025 Technicals & Safe Capital Growth Plans - Newser
Visual trend scoring systems applied to Halozyme Therapeutics Inc.Weekly Stock Summary & Long-Term Growth Stock Strategies - Newser
Are You Looking for a Top Momentum Pick? Why Halozyme Therapeutics (HALO) is a Great Choice - sharewise.com
Connaughton sells Halozyme Therapeutics (HALO) stock worth $294,736 By Investing.com - Investing.com Australia
Halozyme Therapeutics (HALO)A Momentum Leader with Strong Performance - AInvest
Halozyme Therapeutics stock reaches all-time high at 74.79 USD - Investing.com
Halozyme Therapeutics and atai Life Sciences N.V. Lead Medical Stocks with 53.4% and 245.1% Year-to-Date Returns Respectively. - AInvest
Best Momentum Stock to Buy for September 3rd - TradingView
Are Medical Stocks Lagging Halozyme Therapeutics (HALO) This Year? - Yahoo Finance
How to Find Strong Buy Medical Stocks Using the Zacks Rank - Yahoo Finance
Halozyme Therapeutics, Inc. (HALO) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):